1887

Abstract

Molluscum contagiosum virus (MCV) causes persistent, benign skin neoplasm in children and adults. MCV is refractive to growth in standard tissue culture and there is no relevant animal model of infection. Here we investigated whether another poxvirus (vaccinia virus; VACV) could be used to examine MCV immunoevasion protein properties . The MCV or genes, which encode NF-κB antagonists, were inserted into an attenuated VACV lacking an NF-κB antagonist (vΔA49), creating vMC159 and vMC160. vMC160 slightly increased vΔA49 virulence in the intranasal and intradermal routes of inoculation. vMC159 infection was less virulent than vΔA49 in both inoculation routes. vMC159-infected ear pinnae did not form lesions, but virus replication still occurred. Thus, the lack of lesions was not due to abortive virus replication. This system provides a new approach to examine MCV immunoevasion proteins within the context of a complete and complex immune system.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001006
2018-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/2/246.html?itemId=/content/journal/jgv/10.1099/jgv.0.001006&mimeType=html&fmt=ahah

References

  1. Damon IK. Poxviruses. In Fields BN, Knipe DM, Howley PM. (editors) Fields Virology Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013 pp. 2160–2184
    [Google Scholar]
  2. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134:1527–1534 [View Article][PubMed]
    [Google Scholar]
  3. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol 1994; 33:453–461 [View Article][PubMed]
    [Google Scholar]
  4. Shisler JL. Immune evasion strategies of molluscum contagiosum virus. Adv Virus Res 2015; 92:201–252 [View Article][PubMed]
    [Google Scholar]
  5. Vermi W, Fisogni S, Salogni L, Schärer L, Kutzner H et al. Spontaneous regression of highly immunogenic molluscum contagiosum virus (MCV)-induced skin lesions is associated with plasmacytoid dendritic cells and IFN-DC infiltration. J Invest Dermatol 2011; 131:426–434 [View Article][PubMed]
    [Google Scholar]
  6. Senkevich TG, Bugert JJ, Sisler JR, Koonin EV, Darai G et al. Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 1996; 273:813–816 [View Article][PubMed]
    [Google Scholar]
  7. Senkevich TG, Koonin EV, Bugert JJ, Darai G, Moss B. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology 1997; 233:19–42 [View Article][PubMed]
    [Google Scholar]
  8. Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect Dis 2013; 13:877–888 Research Support, Non-U.S. Gov't Review [View Article][PubMed]
    [Google Scholar]
  9. Coutu J, Ryerson MR, Bugert J, Brian Nichols D. The molluscum contagiosum virus protein MC163 localizes to the mitochondria and dampens mitochondrial mediated apoptotic responses. Virology 2017; 505:91–101 [View Article][PubMed]
    [Google Scholar]
  10. Brady G, Haas DA, Farrell PJ, Pichlmair A, Bowie AG. Molluscum contagiosum virus protein MC005 inhibits NF-κB activation by targeting NEMO-regulated IκB kinase activation. J Virol 2017; 91:e00545-17 [View Article][PubMed]
    [Google Scholar]
  11. Brady G, Haas DA, Farrell PJ, Pichlmair A, Bowie AG. Poxvirus protein MC132 from molluscum contagiosum virus inhibits NF-B activation by targeting p65 for degradation. J Virol 2015; 89:8406–8415 [View Article][PubMed]
    [Google Scholar]
  12. Biswas S, Shisler JL. Molluscum contagiosum virus MC159 abrogates cIAP1-NEMO interactions and inhibits NEMO polyubiquitination. J Virol 2017; 91:e00276-17 [View Article][PubMed]
    [Google Scholar]
  13. Nichols DB, Shisler JL. The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-κB activation via inhibition of I kappa kinase complex formation. J Virol 2006; 80:578–586 [View Article][PubMed]
    [Google Scholar]
  14. Nichols DB, Shisler JL. Poxvirus MC160 protein utilizes multiple mechanisms to inhibit NF-κB activation mediated via components of the tumor necrosis factor receptor 1 signal transduction pathway. J Virol 2009; 83:3162–3174 [View Article][PubMed]
    [Google Scholar]
  15. Randall CM, Jokela JA, Shisler JL. The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-κB activation by interacting with the IκB kinase complex. J Immunol 2012; 188:2371–2379 [View Article][PubMed]
    [Google Scholar]
  16. Moss B. Poxviridae, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013
    [Google Scholar]
  17. Reading PC, Smith GL. A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 2003; 84:1973–1983 [View Article][PubMed]
    [Google Scholar]
  18. Tscharke DC, Reading PC, Smith GL. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 2002; 83:1977–1986 [View Article][PubMed]
    [Google Scholar]
  19. Tscharke DC, Smith GL. A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 1999; 80:2751–2755 [View Article][PubMed]
    [Google Scholar]
  20. Smith GL, Benfield CT, Maluquer de Motes C, Mazzon M, Ember SW et al. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 2013; 94:2367–2392 [View Article][PubMed]
    [Google Scholar]
  21. Randall CM, Biswas S, Selen CV, Shisler JL. Inhibition of interferon gene activation by death-effector domain-containing proteins from the molluscum contagiosum virus. Proc Natl Acad Sci USA 2014; 111:E265E272 [View Article][PubMed]
    [Google Scholar]
  22. Mansur DS, Maluquer de Motes C, Unterholzner L, Sumner RP, Ferguson BJ et al. Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog 2013; 9:e1003183 [View Article][PubMed]
    [Google Scholar]
  23. Falkner FG, Moss B. Transient dominant selection of recombinant vaccinia viruses. J Virol 1990; 64:3108–3111[PubMed]
    [Google Scholar]
  24. Shisler JL, Moss B. Molluscum contagiosum virus inhibitors of apoptosis: the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 2001; 282:14–25 [View Article][PubMed]
    [Google Scholar]
  25. Weaver JR, Shamim M, Alexander E, Davies DH, Felgner PL et al. The identification and characterization of a monoclonal antibody to the vaccinia virus E3 protein. Virus Res 2007; 130:269–274 [View Article][PubMed]
    [Google Scholar]
  26. Alcamí A, Smith GL. A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci USA 1996; 93:11029–11034 [View Article][PubMed]
    [Google Scholar]
  27. Bravo Cruz AG, Han A, Roy EJ, Guzmán AB, Miller RJ et al. Deletion of the K1L gene results in a vaccinia virus that is less pathogenic due to muted innate immune responses, yet still elicits protective immunity. J Virol 2017; 91:e00542-17 [View Article][PubMed]
    [Google Scholar]
  28. Berhanu A, King DS, Mosier S, Jordan R, Jones KF et al. ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation. Antimicrob Agents Chemother 2009; 53:4999–5009 [View Article][PubMed]
    [Google Scholar]
  29. Alcamí A, Smith GL. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 1992; 71:153–167 [View Article][PubMed]
    [Google Scholar]
  30. Williamson JD, Reith RW, Jeffrey LJ, Arrand JR, Mackett M. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J Gen Virol 1990; 71:2761–2767 [View Article][PubMed]
    [Google Scholar]
  31. Lin LC, Smith SA, Tscharke DC. An intradermal model for vaccinia virus pathogenesis in mice. Methods Mol Biol 2012; 890:147–159 [View Article][PubMed]
    [Google Scholar]
  32. Fischer MA, Davies ML, Reider IE, Heipertz EL, Epler MR et al. CD11b+, Ly6G+ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection. PLoS Pathog 2011; 7:e1002374 [View Article][PubMed]
    [Google Scholar]
  33. Tartaglia J, Perkus ME, Taylor J, Norton EK, Audonnet JC et al. NYVAC: a highly attenuated strain of vaccinia virus. Virology 1992; 188:217–232 [View Article][PubMed]
    [Google Scholar]
  34. Parkinson JE, Smith GL. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology 1994; 204:376–390 [View Article][PubMed]
    [Google Scholar]
  35. Tartaglia J, Cox WI, Pincus S, Paoletti E. Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC. Dev Biol Stand 1994; 82:125–129[PubMed]
    [Google Scholar]
  36. Stanford MM, McFadden G, Karupiah G, Chaudhri G. Immunopathogenesis of poxvirus infections: forecasting the impending storm. Immunol Cell Biol 2007; 85:93–102 [View Article][PubMed]
    [Google Scholar]
  37. Shisler JL, Senkevich TG, Berry MJ, Moss B. Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science 1998; 279:102–105 [View Article][PubMed]
    [Google Scholar]
  38. Woelfel M, Bixby J, Brehm MA, Chan FK. Transgenic expression of the viral FLIP MC159 causes lpr/gld-like lymphoproliferation and autoimmunity. J Immunol 2006; 177:3814–3820 [View Article][PubMed]
    [Google Scholar]
  39. Wu Z, Roberts M, Porter M, Walker F, Wherry EJ et al. Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory. J Immunol 2004; 172:6313–6323 [View Article][PubMed]
    [Google Scholar]
  40. Hüttmann J, Krause E, Schommartz T, Brune W. Functional comparison of molluscum contagiosum virus vFLIP MC159 with murine cytomegalovirus M36/vICA and M45/vIRA proteins. J Virol 2015; 90:2895–2905 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001006
Loading
/content/journal/jgv/10.1099/jgv.0.001006
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error